中韩高清无专码区2021曰_色翁荡熄又大又硬又粗又视频图片_波多野结衣乳巨码无在线观看_国产91福利在线播放_国产人妻人伦精品_马来西亚潜水天堂_黄色免费网站下载_免费看黄网站黄污污污热门软件_小莹客厅激情46章至50章视频

Jiangsu Ruishi Biotechnology Co., Ltd. is a high-tech enterprise wholly owned by Shenzhen Ruishi Biotechnology Co., Ltd., integrating the research and development, production, and sales of pharmaceutical intermediates, chemical raw materials, and specialty formulations.

Leveraging the unique advantages of its β-lactamase inhibitor intermediate and active pharmaceutical ingredient (API) production base in reaction types such as azide, metal catalysis, chlorination, cryogenics, ultra-high temperature, and amination, the company develops high-difficulty specialty APIs and intermediates in areas including antivirals, cardiovascular drugs, and weight loss, providing high-value-added and cost-effective products for domestic and international pharmaceutical companies.

Simultaneously, the company possesses internationally leading core technologies such as continuous flow microreaction, asymmetric synthesis, and enzymatic catalysis, deeply participating in and supporting the development of high-end generic drugs and innovative drugs with strong clinical value and core technologies, thereby accelerating drug commercialization.

The company adheres to a strategy that balances endogenous growth and external expansion. Internally, it emphasizes R&D and innovation; externally, it deepens its industrial layout through strategic mergers and acquisitions.